References
- Bouzeko ILT, Ndontsa BL, Mba Nguekeu YM, Awouafack MD, Wong CP, Simo Mpetga JD, Mbouangouere R, Tane P, Morita H. 2019. A new alkylbenzoquinone from Embelia rowlandii Gilg. (Myrsinaceae). Nat Prod Res. 33(13):1909–1915. doi:10.1080/14786419.2018.1479703.
- Chen HJ, Inbaraj BS, Chen BH. 2011. Determination of phenolic acids and flavonoids in Taraxacum formosanum Kitam by liquid chromatography-tandem mass spectrometry coupled with a post-column derivatization technique. IJMS. 13(1):260–285.
- Dang PH, Nguyen HX, Nguyen NT, Le HNT, Nguyen M. 2014. α-Glucosidase inhibitors from the stems of Embelia ribes. Phytother Res. 28(11):1632–1636.
- Dhadde SB, Nagakannan P, Roopesh M, Anand Kumar SR, Thippeswamy BS, Veerapur VP, Badami S. 2016. Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats. Biomed Pharmacother. 77:52–58.
- Dhayalan M, Denison MIJ, L AJ, Krishnan K, N NG. 2017. In vitro antioxidant, antimicrobial, cytotoxic potential of gold and silver nanoparticles prepared using Embelia ribes. Nat Prod Res. 31(4):465–468. doi:10.1080/14786419.2016.1166499.
- Durg S, Veerapur VP, Neelima S, Dhadde SB. 2017. Antidiabetic activity of Embelia ribes, embelin and its derivatives: a systematic review and meta-analysis. Biomed Pharmacother. 86:195–204.
- Hao K, Ali M, Siddiqui AW. 2005. New compounds from the seeds of Embelia ribes Burm. Pharmazie. 60(1):69–67. doi:10.1016/j.biopha.2016.12.00.
- Horai H, Arita M, Kanaya S, Nihei Y, Ikeda T, Suwa K, Ojima Y, Tanaka K, Tanaka S, Aoshima K, et al. 2010. MassBank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom. 45(7):703–714.
- Kumar S, Deshmukh R. 2017. Embelin as a potential drug molecule: a review. J Pharmacogn Nat Prod. 3(3):1–7.
- Li Z, Chen S, Yu X, Li J, Gao X, He J, Chang Y. 2019. Pharmacokinetic and bioavailability studies of Embelin after intravenous and oral administration to rats. Evid Based Complement Alternat Med. 2019:9682495.
- Lin P, Li S, Wang S, Yang Y, Shi J. 2006. A nitrogen-containing 3-alkyl-1,4- benzoquinone and a gomphilactone derivative from Embelia ribes. J Nat Prod. 69(11):1629–1632.
- Manguro LOA, Ugi I, Lemmen P. 2005. Flavonol Glycosides from the Leaves of Embelia keniensis. J Chinese Chem Soc. 52(1):201–208.
- Martucci MEP, De Vos RCH, Carollo CA, Gobbo-Neto L. 2014. Metabolomics as a potential chemotaxonomical tool: application in the genus Vernonia Schreb. PLoS One. 9(4):e93149.
- Nikolovska-Coleska Z, Xu L, Hu Z, Tomita Y, Li P, Roller PP, Wang R, Fang X, Guo R, Zhang M, et al. 2004. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem. 47(10):2430–2440.
- Simirgiotis M, Benites J, Areche C, Sepúlveda B. 2015. Antioxidant capacities and analysis of phenolic compounds in three endemic Nolana species by HPLC-PDA-ESI-MS. Molecules. 20(6):11490–11507.
- Souravi K, Rajasekharan PE. 2014. A review on the pharmacology of Embelia ribes burm.f.-a threatened medicinal plant. Int J Pharm Bio Sci. 5(2):443–456.